Yantai, Shandong Province-based Chinese drug-maker Luye Pharma Group has priced its Hong Kong IPO, planning to sell 999.6 million shares at HK$5.38 to HK$5.92 each,... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
